The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey

• Main Authors: Jerold Jeyaratnam (Author), Nienke M. ter Haar (Author), Helen J. Lachmann (Author), Ozgur Kasapcopur (Author), Amanda K. Ombrello (Author), Donato Rigante (Author), Fatma Dedeoglu (Author), Ezgi H. Baris (Author), Sebastiaan J. Vastert (Author), Nico M. Wulffraat (Author), Joost Frenkel (Author)
• Format: Book
• Published: BMC, 2018-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Withholding live-attenuated vaccines in patients using interleukin (IL)-1 or IL-6 blocking agents is recommended by guidelines for both pediatric and adult rheumatic diseases, since there is a risk of infection in an immune suppressed host. However, this has never been studied. T...